Academic Bibliography

Search 200 years of publications by Ghent University researchers.

Ben Wielockx

Show Sort by

Add to list
Haematopoietic prolyl hydroxylase-1 deficiency promotes M2 macrophage polarization and is both necessary and sufficient to protect against experimental colitis

Sophie Van Welden (UGent) , Martine De Vos (UGent) , Ben Wielockx, Simon Tavernier (UGent) , Melissa Dullaers (UGent) , Sara Neyt (UGent) , Benedicte Descamps (UGent) , Lindsey Devisscher (UGent) , Sarah Devriese, Lien Van den Bossche (UGent) , et al.

(2017) JOURNAL OF PATHOLOGY. 241(4). p.547-558
Add to list
Involvement of specific matrix metalloproteinases during tumor necrosis factor/IFN gamma-based cancer therapy in mice

Maarten Van Roy, Philippe Van Lint (UGent) , I VAN LAERE, Ben Wielockx, C WILSON, C LOPEZ-OTIN, S SHAPIRO and Claude Libert (UGent)

(2007) MOLECULAR CANCER THERAPEUTICS. 6(9). p.2563-2571
Add to list
Description and mapping of the resistance of DBA/2 mice to TNF-induced lethal shock

Ben Wielockx, Jan Staelens, Leen Puimège (UGent) , Ineke Vanlaere (UGent) , Maarten Van Roy, Philippe Van Lint, Frans Van Roy (UGent) and Claude Libert (UGent)

(2007) JOURNAL OF IMMUNOLOGY. 178(8). p.5069-5075
Add to list
The use of tissue inhibitors of matrix metalloproteinases to increase the efficacy of a tumor necrosis factor/interferon gamma antitumor therapy

Maarten Van Roy, Ben Wielockx, A BAKER and Claude Libert (UGent)

(2007) CANCER GENE THERAPY. 14(4). p.372-379
Add to list
Resistance of collagenase-2 (matrix metalloproteinase-8)-deficient mice to TNF-induced lethal hepatitis

Philippe Van Lint, Ben Wielockx, Leen Puimège (UGent) , Agnès Noël, Carlos López-Otin and Claude Libert (UGent)

(2005) JOURNAL OF IMMUNOLOGY. 175(11). p.7642-7649
Add to list
Adenoviral gene transfer of ABIN-1 protects mice from TNF/galactosamine-induced acute liver failure and lethality

Andy Wullaert (UGent) , Ben Wielockx, Sofie Van Huffel, Veerle Bogaert (UGent) , B DE GEEST, P PAPELEU, Peter Schotte, Karim El Bakkouri (UGent) , Karen Heyninck (UGent) , Claude Libert (UGent) , et al.

(2005) HEPATOLOGY. 42(2). p.381-389
Add to list
Contribution of host MMP-2 and MMP-9 to promote tumor vascularization and invasion of malignant keratinocytes

V MASSON, LR DE LA BALLINA, C MUNAUT, Ben Wielockx, M JOST, C MAILLARD, S BLACHER, K BAJOU, T ITOH, S ITOHARA, et al.

(2004) FASEB JOURNAL. 18(14).
Add to list
Matrilysin (matrix metalloproteinase-7): a new promising drug target in cancer and inflammation?

Ben Wielockx, Claude Libert (UGent) and C WILSON

(2004) CYTOKINE & GROWTH FACTOR REVIEWS. 15(2-3). p.111-115
Add to list
MMP-2 and MMP-9 synergize in promoting choroidal neovascularization

V LAMBERT, Ben Wielockx, C MUNAUT, C GALOPIN, M JOST, T ITOH, Z WERB, A BAKER, Claude Libert (UGent) , HW KRELL, et al.

(2003) FASEB JOURNAL. 17(13).
Add to list
Serine proteases of the fibrinolysis pathway are not involved in lethal hepatitis and fibrinogen breakdown induced by tumor necrosis factor

Ben Wielockx and Claude Libert (UGent)

(2003) CYTOKINE. 21(6). p.281-285
Add to list
Hyporesponsiveness of SPRET/Ei mice to lethal shock induced by tumor necrosis factor and implications for a TNF-based antitumor therapy

Jan Staelens, Ben Wielockx, Leen Puimège (UGent) , Frans Van Roy (UGent) , Jean-Louis Guénet and Claude Libert (UGent)

(2002) PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 99(14). p.9340-9345
Add to list
HSP70 protects against TNF-induced lethal inflammatory shock.

Wim Van Molle, Ben Wielockx, Tina Mahieu, M TAKADA, T TANIGUCHI, K SEKIKAWA and Claude Libert (UGent)

(2002) IMMUNITY. 16(5). p.685-695
Add to list
Detection, characterisation and purification of a murine liver factor capable of desensitising towards the lethal activity of tumour necrosis factor.

Ben Wielockx, Tino Hochepied (UGent) , Jan Staelens, Wim Van Molle, Peter Brouckaert (UGent) and Claude Libert (UGent)

(2001) CYTOKINE. 15(2). p.59-65
Add to list
Involvement of a serine protease, but not of neutrophil elastase, in tumor necrosis factor-induced lethal hepatitis and induction of platelet-activating factor.

Ben Wielockx, F BUSSOLINO, SD SHAPIRO and Claude Libert (UGent)

(2001) JOURNAL OF HEPATOLOGY. 35(4). p.490-497
Add to list
Inhibition of matrix metalloproteinases blocks lethal hepatitis and apoptosis induced by tumor necrosis factor and allows safe antitumor therapy.

Ben Wielockx, K LANNOY, SD SHAPIRO, T ITOH, S ITOHARA, Joël Vandekerckhove (UGent) and Claude Libert (UGent)

(2001) NATURE MEDICINE. 7(11). p.1202-1208
Add to list
Identification of a locus on distal mouse chromosome 12 that controls resistance to tumor necrosis factor-induced lethal shock.

Claude Libert (UGent) , Ben Wielockx, GL HAMMOND, Peter Brouckaert (UGent) , Walter Fiers and RW ELLIOTT

(1999) GENOMICS. 55(3). p.284-289
Add to list
The role of complement activation in tumour necrosis factor-induced lethal hepatitis.

Claude Libert (UGent) , Ben Wielockx, B GRIJALBA, Wim Van Molle, E KREMMER, HR COLTEN, Walter Fiers and Peter Brouckaert (UGent)

(1999) CYTOKINE. 11(8). p.617-625